Logo image of EXO.AS

EXOR NV (EXO.AS) Stock Fundamental Analysis

AMS:EXO - Euronext Amsterdam - NL0012059018 - Common Stock - Currency: EUR

90.7  -0.55 (-0.6%)

Fundamental Rating

5

Taking everything into account, EXO scores 5 out of 10 in our fundamental rating. EXO was compared to 50 industry peers in the Financial Services industry. While EXO belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. EXO has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

In the past year EXO was profitable.
In the past year EXO had a positive cash flow from operations.
Of the past 5 years EXO 4 years were profitable.
Each year in the past 5 years EXO had a positive operating cash flow.
EXO.AS Yearly Net Income VS EBIT VS OCF VS FCFEXO.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

Looking at the Return On Assets, with a value of 34.55%, EXO belongs to the top of the industry, outperforming 98.00% of the companies in the same industry.
EXO's Return On Equity of 38.39% is amongst the best of the industry. EXO outperforms 88.00% of its industry peers.
With an excellent Return On Invested Capital value of 26.91%, EXO belongs to the best of the industry, outperforming 92.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for EXO is above the industry average of 11.55%.
The 3 year average ROIC (13.67%) for EXO is below the current ROIC(26.91%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 34.55%
ROE 38.39%
ROIC 26.91%
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)13.67%
ROIC(5y)9.18%
EXO.AS Yearly ROA, ROE, ROICEXO.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

EXO's Profit Margin of 95.30% is amongst the best of the industry. EXO outperforms 98.00% of its industry peers.
In the last couple of years the Profit Margin of EXO has grown nicely.
EXO's Operating Margin of 96.43% is amongst the best of the industry. EXO outperforms 100.00% of its industry peers.
EXO's Operating Margin has improved in the last couple of years.
The Gross Margin of EXO (100.00%) is better than 100.00% of its industry peers.
EXO's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 96.43%
PM (TTM) 95.3%
GM 100%
OM growth 3Y119.43%
OM growth 5Y70.93%
PM growth 3Y165.23%
PM growth 5Y113.99%
GM growth 3Y61.62%
GM growth 5Y43.9%
EXO.AS Yearly Profit, Operating, Gross MarginsEXO.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

EXO has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for EXO has been reduced compared to 1 year ago.
Compared to 5 years ago, EXO has less shares outstanding
The debt/assets ratio for EXO has been reduced compared to a year ago.
EXO.AS Yearly Shares OutstandingEXO.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
EXO.AS Yearly Total Debt VS Total AssetsEXO.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

An Altman-Z score of 5.44 indicates that EXO is not in any danger for bankruptcy at the moment.
EXO's Altman-Z score of 5.44 is amongst the best of the industry. EXO outperforms 82.00% of its industry peers.
EXO has a debt to FCF ratio of 87.02. This is a negative value and a sign of low solvency as EXO would need 87.02 years to pay back of all of its debts.
EXO has a worse Debt to FCF ratio (87.02) than 74.00% of its industry peers.
EXO has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.08, EXO is in the better half of the industry, outperforming 78.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 87.02
Altman-Z 5.44
ROIC/WACC5.21
WACC5.17%
EXO.AS Yearly LT Debt VS Equity VS FCFEXO.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 0.19 indicates that EXO may have some problems paying its short term obligations.
EXO has a worse Current ratio (0.19) than 76.00% of its industry peers.
EXO has a Quick Ratio of 0.19. This is a bad value and indicates that EXO is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of EXO (0.19) is worse than 76.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
EXO.AS Yearly Current Assets VS Current LiabilitesEXO.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 262.89% over the past year.
The Earnings Per Share has been growing by 38.47% on average over the past years. This is a very strong growth
EXO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -65.59%.
Measured over the past years, EXO shows a very negative growth in Revenue. The Revenue has been decreasing by -36.03% on average per year.
EPS 1Y (TTM)262.89%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-101.27%
Revenue 1Y (TTM)-65.59%
Revenue growth 3Y-22.92%
Revenue growth 5Y-36.03%
Sales Q2Q%-98.91%

3.2 Future

The Earnings Per Share is expected to decrease by -49.89% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-77.23%
EPS Next 2Y-52.5%
EPS Next 3Y-49.89%
EPS Next 5YN/A
Revenue Next Year6.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EXO.AS Yearly Revenue VS EstimatesEXO.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B
EXO.AS Yearly EPS VS EstimatesEXO.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10 20 30

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 1.36, the valuation of EXO can be described as very cheap.
Based on the Price/Earnings ratio, EXO is valued cheaply inside the industry as 96.00% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 28.04. EXO is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 11.65, the valuation of EXO can be described as reasonable.
EXO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EXO is cheaper than 70.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 37.64. EXO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 1.36
Fwd PE 11.65
EXO.AS Price Earnings VS Forward Price EarningsEXO.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EXO is valued cheaply inside the industry as 92.00% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, EXO is valued a bit more expensive than 74.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 400.97
EV/EBITDA 1.54
EXO.AS Per share dataEXO.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

EXO has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as EXO's earnings are expected to decrease with -49.89% in the coming years.
PEG (NY)N/A
PEG (5Y)0.04
EPS Next 2Y-52.5%
EPS Next 3Y-49.89%

More info and screens

2

5. Dividend

5.1 Amount

EXO has a yearly dividend return of 0.54%, which is pretty low.
Compared to an average industry Dividend Yield of 3.62, EXO has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.35, EXO's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.54%

5.2 History

The dividend of EXO decreases each year by -47.20%.
Dividend Growth(5Y)-47.2%
Div Incr Years2
Div Non Decr Years2
EXO.AS Yearly Dividends per shareEXO.AS Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

0.67% of the earnings are spent on dividend by EXO. This is a low number and sustainable payout ratio.
EXO's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP0.67%
EPS Next 2Y-52.5%
EPS Next 3Y-49.89%
EXO.AS Yearly Income VS Free CF VS DividendEXO.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B
EXO.AS Dividend Payout.EXO.AS Dividend Payout, showing the Payout Ratio.EXO.AS Dividend Payout.PayoutRetained Earnings

More info and screens

EXOR NV

AMS:EXO (7/25/2025, 7:00:00 PM)

90.7

-0.55 (-0.6%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)03-26 2025-03-26/amc
Earnings (Next)09-17 2025-09-17
Inst Owners26.77%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap18.85B
Analysts85
Price Target118.61 (30.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.54%
Yearly Dividend0.46
Dividend Growth(5Y)-47.2%
DP0.67%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.12%
PT rev (3m)-5.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 1.36
Fwd PE 11.65
P/S 1.22
P/FCF 400.97
P/OCF 400.97
P/B 0.49
P/tB 0.49
EV/EBITDA 1.54
EPS(TTM)66.88
EY73.74%
EPS(NY)7.79
Fwd EY8.59%
FCF(TTM)0.23
FCFY0.25%
OCF(TTM)0.23
OCFY0.25%
SpS74.09
BVpS183.91
TBVpS183.91
PEG (NY)N/A
PEG (5Y)0.04
Profitability
Industry RankSector Rank
ROA 34.55%
ROE 38.39%
ROCE 35.89%
ROIC 26.91%
ROICexc 27.01%
ROICexgc 27.03%
OM 96.43%
PM (TTM) 95.3%
GM 100%
FCFM 0.31%
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)13.67%
ROIC(5y)9.18%
ROICexc(3y)14.71%
ROICexc(5y)10.09%
ROICexgc(3y)16.03%
ROICexgc(5y)11.47%
ROCE(3y)18.23%
ROCE(5y)12.24%
ROICexcg growth 3Y82.33%
ROICexcg growth 5Y13.41%
ROICexc growth 3Y91.95%
ROICexc growth 5Y26.23%
OM growth 3Y119.43%
OM growth 5Y70.93%
PM growth 3Y165.23%
PM growth 5Y113.99%
GM growth 3Y61.62%
GM growth 5Y43.9%
F-Score6
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 87.02
Debt/EBITDA 0.2
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 170.63
Cash Conversion 0.32%
Profit Quality 0.32%
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z 5.44
F-Score6
WACC5.17%
ROIC/WACC5.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)46.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)262.89%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-101.27%
EPS Next Y-77.23%
EPS Next 2Y-52.5%
EPS Next 3Y-49.89%
EPS Next 5YN/A
Revenue 1Y (TTM)-65.59%
Revenue growth 3Y-22.92%
Revenue growth 5Y-36.03%
Sales Q2Q%-98.91%
Revenue Next Year6.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y139.47%
EBIT growth 3Y69.13%
EBIT growth 5Y9.34%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-98.63%
FCF growth 3Y-69.35%
FCF growth 5Y-53.45%
OCF growth 1Y-99.25%
OCF growth 3Y-76.44%
OCF growth 5Y-67.23%